INmune Bio Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 1.6 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 49.21M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
INmune Bio Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company’s development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, which is in Phase II for the treatment of breast cancer. It provides XPro1595 for the treatment of Alzheimer’s disease and treatment resistant depression; and CORDstrom, a cell suspension for intravenous infusion or injection comprising aseptic, allogeneic, and pooled HucMSCs. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; GOSH; and University of Pittsburg. The company was incorporated in 2015 and is headquartered in Boca Raton, Florida.
Details
| Name | INmune Bio Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 21 |
| Founded | 2015 |
| Ipo Date | 2019-02-04 |
| Ceo | David Moss |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 8.00 |
| Isin | US45782T1051 |
| Cusip | 45782T105 |
| Cik | 0001711754 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| David J. Moss M.B.A. | President, Chief Executive Officer, Treasurer, Secretary and Director |
| Cory Randall Ellspermann | Interim Chief Financial Officer |
| Dr. Mark William Lowdell Ph.D. | Co-Founder, Chair of Scientific Advisory Board, CSO and Chief Manufacturing Officer |
| Daniel Frederick Carlson | Head of Investor Relations |
| Joshua S. Schoonover Esq. | General Counsel |
Contact
| Address | 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432, United States |
| Phone | 561 710 0512 |
| Website | https://www.inmunebio.com |